期刊
CURRENT ALLERGY AND ASTHMA REPORTS
卷 15, 期 3, 页码 -出版社
CURRENT MEDICINE GROUP
DOI: 10.1007/s11882-014-0509-6
关键词
Asthma; Chronic obstructive pulmonary disease; COPD; Asthma COPD overlap syndrome; ACOS; COPD phenotypes
资金
- BI
- Genentech
- GSK
- Sunovion
- Mylan
- Novartis
- Pfizer
- Pearl
Asthma and chronic obstructive pulmonary disease (COPD) have traditionally been viewed as distinct clinical entities. Recently, however, much attention has been focused on patients with overlapping features of both asthma and COPD: those with asthma COPD overlap syndrome (ACOS). Although no universal definition criteria exist, recent publications attempted to define patients with ACOS based on differences in clinical features, radiographic findings, and diagnostic tests. Patients with ACOS make up a large percentage of those with obstructive lung disease and have a higher overall health-care burden. Identifying patients with ACOS has significant therapeutic implications particularly with the need for early use of inhaled corticosteroids and the avoidance of use of long-acting bronchodilators alone in such patients. However, unlike asthma and COPD, no evidence-based guidelines for the management of ACOS currently exist. Future research is needed to improve our understanding of ACOS and to achieve the best management strategies.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据